/**/ document.writeln("\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
MarketsQuoteDepth/LIIChartsNewsHistorical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n
powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Synta Pharmaceuticals Corp. (SNTA) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 3.82\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n 0.00\n\n (0.00%)\n\n \n\n \n\n \n\n \n\n Volume: 34.09 k\n\n \n\n \n\n\n\n 4:00 PM EST Nov 20, 2009\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
February 02,2009
\n \n
Close: \n 9.55\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
March 02,2009
\n \n
Close: \n 1.20\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n
\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
3.82
\n
\n\n \n \n \n
Change $
\n \n \n \n
\n
\n \n\n \n \n
Change %
\n\n \n \n \n
\n
\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
3.27
\n
\n \n \n \n\n
Bid Size
100
\n
\n \n \n \n
Ask
4.37
\n\n
\n \n \n \n
Ask Size
100
\n
\n \n \n \n
Open
3.81
\n
\n \n \n \n
High
3.85
\n
\n\n \n \n \n
Low
3.7501
\n
\n \n\n \n \n
Prev Close
3.82
\n
\n \n\n \n \n
Last Trade
11/20/09
\n
\n \n \n \n
Volume
34.09 k
\n
\n \n \n \n
\n
52 Wk Hi
9.55
\n
\n\n \n \n \n
52 Wk Low
1.20
\n
\n \n\n \n \n
Market Cap
129.8 m
\n
\n \n \n \n
Ex-Div Date
N/A
\n
\n \n \n \n \n \n\n
Div Rate
0.00
\n
\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
33,978,300
\n
\n \n \n \n
EPS (TTM)
1.77
\n
\n \n \n \n\n
PE Ratio
2.20
\n
\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
NASDAQ (NSD)
\n
\n
\n
\n
\n
\n \n
Exchange
NSD
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Synta Pharmaceuticals Corp.\n\n \n\n  (SNTA) \n\n \n\n \n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking &\nFinance
\n\n
Capital Gains
\n
Mergers &\nAcquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary\nFund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for SNTA\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 19, 2009
\n\n \n\n\n\n
6:52 AM\n\n\n\n Trading Overview for Sinobiopharma Inc. Issued by StockPreacher.com - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 18, 2009
\n\n \n\n\n\n
8:01 AM\n\n\n\n Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090 - Business Wire
8:00 AM\n\n\n\n Synta Presents New Data on Mechanism of Action of Elesclomol at AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 11, 2009
\n\n \n\n\n\n
8:30 AM\n\n\n\n Synta Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 04, 2009
\n\n \n\n\n\n
7:00 AM\n\n\n\n Synta Pharmaceuticals Reports Third Quarter 2009 Financial Results - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Oct 12, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Synta Pharmaceuticals Announces Updated Elesclomol SYMMETRYSM Data Presented at Melanoma XIII - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Oct 09, 2009
\n\n \n\n\n\n
9:11 AM\n\n\n\n Griffin Securities Announces Investment Opinion on Targeting Cancer Stem Cells - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Sep 29, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Synta Pharmaceuticals Initiates Fourth Trial of STA-9090, a Novel Synthetic Small Molecule Hsp90 Inhibitor - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Sep 03, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Synta Pharmaceuticals to Present at the R.W. Baird Healthcare Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, May 20, 2008
\n\n \n\n\n\n
9:00 AM\n\n\n\n Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, May 09, 2008
\n\n \n\n\n\n
8:00 PM\n\n\n\n Semi-Annual Changes to the NASDAQ Biotechnology Index - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Mar 06, 2008
\n\n \n\n\n\n
6:11 PM\n\n\n\n QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Feb 13, 2008
\n\n \n\n\n\n
10:43 AM\n\n\n\n WallSt.net (www.WallSt.net) Updates the Investment Community Through All-New Interviews With PSMH, SNTA, and AEZS - PR Newswire
\n\n More News for SNTA >>
\n\n
\n\n
\n\n\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n\n DL+   Realtime BATS,  \n\n EOD   End Of Day,  \n\n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");